SGLT-2 inhibition a useful tool in the treatment of heart failure with reduced and preserved ejection fraction

Autor:	Jiří, Slíva
Rok vydání:	2022
Předmět:	Heart Failure Diabetes Mellitus Type 2 Internal Medicine Humans Stroke Volume Cardiology and Cardiovascular Medicine Sodium-Glucose Transporter 2 Inhibitors Ventricular Function Left
Zdroj:	Vnitřní lékařství. 68:393-397
ISSN:	1801-7592 0042-773X
DOI:	10.36290/vnl.2022.080
Popis:	Heart failure is highly prevalent in the population and, from a long-term point of view, a disease that is still difficult to treat. Although a number of medicinal solutions are offered in its treatment, there are still large reserves. The drug portfolio has recently been expanded to include the use of SGLT-2 inhibitors, initially for failure with reduced and now also with preserved ejection fraction. The question of the possibility of using these substances is discussed in the text, focusing on a possible explanation of their therapeutic benefit.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::799db3e84c007b1182be654eff27e69f https://doi.org/10.36290/vnl.2022.080 Zobrazit plný text záznamu